What's new

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 23, Status: Authorised

May 8, 2025 - 11:02
 0
Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, D...

Next Article

With congested waterways, Singapore focused on modernizing navy

Related Posts

Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Date of authorisation: 26/04/2021, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0

Business process description for paediatric medicines d...

Apr 22, 2025  0